![Biognosys](https://storage.googleapis.com/dealroom-images-production/c9/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDIzLzAxLzEyLzliNDNkMjFlNWUyMjlkZTdiNzFhNTliYzZhNTAzNmFl.png)
Biognosys
VerifiedThe leader in targeted proteomics and at the forefront of personalized healthcare development..
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$20—30m (Dealroom.co estimates Jul 2017.)
Company register number CHE-114.490.102
Schlieren Canton of Zürich (HQ)
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor | $0.0 | round |
investor investor | $0.0 | round | |
N/A | $0.0 | round | |
N/A | $0.0 | round | |
investor investor investor | $0.0 | round | |
N/A | $0.0 | round | |
* | CHF75.0m | Acquisition | |
Total Funding | 000k |
Related Content
Recent News about Biognosys
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.